273 related articles for article (PubMed ID: 25840630)
1. Evaluation of asthma control by inhaled corticosteroids in general practice in Thailand.
Boonsawat W; Boonsawat W; Thinkhamrop B
Asian Pac J Allergy Immunol; 2015 Mar; 33(1):21-5. PubMed ID: 25840630
[TBL] [Abstract][Full Text] [Related]
2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
3. Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.
Chantaphakul H; Ruxrungtham K
Expert Opin Pharmacother; 2016; 17(5):631-42. PubMed ID: 26799114
[TBL] [Abstract][Full Text] [Related]
4. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
[TBL] [Abstract][Full Text] [Related]
5. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
6. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
7. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
[TBL] [Abstract][Full Text] [Related]
8. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
9. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids.
Elkout H; McLay JS; Simpson CR; Helms PJ
Arch Dis Child; 2010 Oct; 95(10):817-21. PubMed ID: 20656730
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
[TBL] [Abstract][Full Text] [Related]
11. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
12. Assessment of asthma control: the SERENA study.
Corrado A; Renda T; Polese G; Rossi A;
Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118
[TBL] [Abstract][Full Text] [Related]
13. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
Hozawa S; Haruta Y; Terada M; Yamakido M
Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic interventions to reduce the risk of asthma exacerbations.
O'Byrne PM
Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
[TBL] [Abstract][Full Text] [Related]
15. Balancing safety and efficacy in pediatric asthma management.
Skoner DP
Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
[TBL] [Abstract][Full Text] [Related]
16. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
17. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
[TBL] [Abstract][Full Text] [Related]
18. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
[TBL] [Abstract][Full Text] [Related]
19. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.
Davidsen JR
Dan Med J; 2012 Aug; 59(8):B4501. PubMed ID: 22849986
[TBL] [Abstract][Full Text] [Related]
20. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
